Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic polymorphisms and head and neck cancer outcomes: a review.
Hopkins J, Cescon DW, Tse D, Bradbury P, Xu W, Ma C, Wheatley-Price P, Waldron J, Goldstein D, Meyer F, Bairati I, Liu G. Hopkins J, et al. Among authors: ma c. Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):490-9. doi: 10.1158/1055-9965.EPI-07-2714. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18349267 Review.
p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C, Xu W, Marshall AL, Heist RS, Wain JC, Lynch TJ Jr, Christiani DC, Liu G. Cescon DW, et al. Among authors: ma c. Clin Cancer Res. 2009 May 1;15(9):3103-9. doi: 10.1158/1078-0432.CCR-08-3120. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383811 Free PMC article.
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.
Bradbury PA, Kulke MH, Heist RS, Zhou W, Ma C, Xu W, Marshall AL, Zhai R, Hooshmand SM, Asomaning K, Su L, Shepherd FA, Lynch TJ, Wain JC, Christiani DC, Liu G. Bradbury PA, et al. Among authors: ma c. Pharmacogenet Genomics. 2009 Aug;19(8):613-25. doi: 10.1097/FPC.0b013e32832f3010. Pharmacogenet Genomics. 2009. PMID: 19620936 Free PMC article.
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit.
Wheatley-Price P, Ma C, Ashcroft LF, Nankivell M, Stephens RJ, White SC, Lorigan P, Thatcher N, Blackhall FH, Shepherd FA. Wheatley-Price P, et al. Among authors: ma c. Ann Oncol. 2010 Feb;21(2):232-237. doi: 10.1093/annonc/mdp300. Epub 2009 Aug 12. Ann Oncol. 2010. PMID: 19675093 Free article.
Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer.
Lara-Guerra H, Waddell TK, Salvarrey MA, Joshua AM, Chung CT, Paul N, Boerner S, Sakurada A, Ludkovski O, Ma C, Squire J, Liu G, Shepherd FA, Tsao MS, Leighl NB. Lara-Guerra H, et al. Among authors: ma c. J Clin Oncol. 2009 Dec 20;27(36):6229-36. doi: 10.1200/JCO.2009.22.3370. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884551 Clinical Trial.
17,132 results
You have reached the last available page of results. Please see the User Guide for more information.